Biopharmaceutical current status

Tomaro-Duchesneau, C., Saha, S., MaUiotra, M., Kahouli, I., Prakash, S., 2012. Microencapsulation for the therapeutic deUvery of dmgs, live mammalian and bacterial cells, and other biopharmaceutics current status and future directions. Journal of Pharmaceutics 2013, el03527. 

Kramer J. The biopharmaceutics classification system—an overview of the current status in relation to IR and MR dosage forms. 1st International Conference on Bioavailability, Bioequivalence and Dissolution Testing, London, 2002. 

Lennernas H and Abrahamsson B (2005) The Use of Biopharmaceutic Classification of Drugs in Drug Discovery and Development Current Status and Future Extension. J Pharm Pharmacol 57 pp 273-285. 

Lennernas H, Abrahamsson B (2005) The use of biopharmaceutic classification of drugs in drug discovery and development Current status and future extension. J Pharm Pharmacol 57 273-285. 

The purpose of this overview chapter is to provide perspectives in the current status and future prospects of controlled release drug delivery. This is accomplished by examining various delivery systems from a mechanistic point of view, exploring applications of these systems, and discussing relevant biopharmaceutical parameters. A major section of this book is devoted to fundamental issues and applications of transdermal and transmucosal delivery systems (Chapter 6,8,17-23). Other developing systems of future potential... 

Current Status of Biopharmaceuticals Approved Products and Trends in Approvals... 

I Current Status of Biopharmaceuticals Approved Products and Trends in Approvals Tables Recombinant hemopoietic growth factors approved for general medical use... 

---